The prognostic significance of derivative chromosome 9 deletions in Chinese patients with chronic myelogenous leukemia

被引：0
|
作者：
Li, Jian-Yong [1 ]
Xu, Wei [1 ]
Wu, Wei [1 ]
Zhu, Yu [1 ]
Qiu, Hai-Rong [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2007年 / 29卷
关键词：
D O I：
10.1504/IJCAT.2007.015244
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
816
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [31] SPLEEN SIZE AND CHROMOSOME ANALYSIS AS PROGNOSTIC FACTORS IN CHRONIC MYELOGENOUS LEUKEMIA
    COLLINS, RK
    JACKSON, JF
    MORRISON, FS
    MEYDRECH, EF
    SOUTHERN MEDICAL JOURNAL, 1979, 72 (06) : 642 - &
  • [32] ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia
    de la Fuente, J
    Merx, K
    Steer, EJ
    Müller, M
    Szydlo, RM
    Maywald, O
    Berger, U
    Hehlmann, R
    Goldman, JM
    Cross, NCP
    Melo, JV
    Hochhaus, A
    BLOOD, 2001, 98 (09) : 2879 - 2880
  • [33] Tumor suppressor genes loss in chronic myeloid leukemia cases bearing derivative chromosome 9 deletions.
    Specchia, G
    Albano, F
    Anelli, L
    Storlazzi, CT
    Zagaria, A
    Pannunzio, A
    Rocchi, M
    Liso, V
    BLOOD, 2002, 100 (11) : 321B - 321B
  • [34] ABL or BCR gene deletion on derivative chromosome 9 may be a powerful prognostic marker in chromic myelogenous leukemia.
    Lee, DS
    Kim, YR
    Cho, HI
    Lee, YK
    Yoon, SS
    BLOOD, 2002, 100 (11) : 239B - 239B
  • [35] SIGNIFICANCE AND CORRELATIONS OF MOLECULAR ANALYSIS RESULTS IN PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA AND CHRONIC MYELOMONOCYTIC LEUKEMIA
    KANTARJIAN, HM
    SHTALRID, M
    KURZROCK, R
    BLICK, M
    DALTON, WT
    LEMAISTRE, A
    STASS, SA
    MCCREDIE, KB
    GUTTERMAN, J
    FREIREICH, EJ
    TALPAZ, M
    AMERICAN JOURNAL OF MEDICINE, 1988, 85 (05): : 639 - 644
  • [36] PROGNOSTIC-SIGNIFICANCE OF THE MORPHOLOGICAL DYSPLASTIC CHANGES IN CHRONIC MYELOGENOUS LEUKEMIA
    MATSUO, T
    TOMONAGA, M
    KURIYAMA, K
    YAO, E
    NONAKA, H
    JINNAI, I
    JUBASHI, T
    YOSHIDA, Y
    AMENOMORI, T
    ICHIMARU, M
    LEUKEMIA RESEARCH, 1986, 10 (03) : 331 - 337
  • [37] Prognostic Significance of Chromosomal Aberrations in Philadelphia Chromosome Negative Metaphases during Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia
    Batra, R.
    Weisenburger, D.
    Snyder, D.
    Bedell, V.
    Murata-Collins, J.
    Gaal, K.
    MODERN PATHOLOGY, 2014, 27 : 335A - 335A
  • [38] Deletions of the derivative chromosome 9 do not influence response to imatinib in early chronic phase chronic myeloid leukemia patients: A GIMEMA CML WP analysis
    Castagnetti, F.
    Luatti, S.
    Marzocchi, G.
    Palandri, F.
    Amabile, M.
    Soverini, S.
    Mancini, M.
    Kerim, S.
    Giugliano, E.
    Specchia, G.
    Cuneo, A.
    Abruzzese, E.
    Martinelli, G.
    Testoni, N.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 180 - 181
  • [39] Deletion of any of BCR or ABL gene on derivative chromosome 9 is a poor prognostic marker that indicates rapid disease progression in chronic myelogenous leukemia.
    Lee, YK
    Kim, YR
    She, CJ
    Yoon, SS
    Kim, YS
    Cho, HI
    Kim, HC
    Lee, YS
    Lee, DS
    BLOOD, 2005, 106 (11) : 196B - 196B
  • [40] Prognostic Significance of Chromosomal Aberrations in Philadelphia Chromosome Negative Metaphases during Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia
    Batra, R.
    Weisenburger, D.
    Snyder, D.
    Bedell, V.
    Murata-Collins, J.
    Gaal, K.
    LABORATORY INVESTIGATION, 2014, 94 : 335A - 335A
12345